X

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. If you have any questions related to this announcement, please contact your healthcare provider or your One to One Nurse at 1-855-557-2483.

MAT-US-2015317

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA EXPERIENCES
CLICK TO SWITCH

SEE HOW LEMTRADA PATIENTS TALK ABOUT THEIR RELAPSING MS TREATMENT GOALS

Food safety tips for before, during, and after LEMTRADA treatment

THE RECIPE FOR FOOD SAFETY DURING MULTIPLE SCLEROSIS TREATMENT

By The LEMTRADA Team

Enjoying meals and snacks safely before, during, and after your treatment courses is easy if you
follow these food safety tips…

READ MORE


An article written by a LEMTRADA patient sharing how he makes a commitment to monitoring

MONTHLY MONITORING WITH LEMTRADA

By Donnie, Father, Husband, Project Leader, Former Athlete

LEMTRADA patient Donnie discusses how he made monthly monitoring a part of his regular
treatment routine.

READ MORE


An article written by a LEMTRADA patient discussing the side effects she experienced during treatment

MY EXPERIENCE WITH SIDE EFFECTS

By Rachel, Wife, Mother, Domestic Engineer

Even though my healthcare team had thoroughly prepared me and explained potential infusion-
related side effects and long-term side effects, this was all uncharted territory for me…

READ MORE


An article written by a LEMTRADA patient sharing what he experienced on treatment days

My LEMTRADA infusion-day experiences

By Chad, Husband, Father, Software Engineer

Since I have personal experience with LEMTRADA infusions, I’ll fill you in on one of my typical
treatment days, so you have an idea of what to expect…

READ MORE


An article written by a LEMTRADA patient sharing her experience with post-infusion fatigue

TAKING IT SLOWLY: BE MINDFUL OF POST-INFUSION FATIGUE

By Kimberly, Texas Gal, Born and Raised

Why is it so important to understand how to take care of yourself after your infusion? Well, let
me explain, using my own personal experience…

READ MORE


TAP TO SWITCH
Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: